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Background. During tuberculosis treatment, patients may transfer to continue treatment at another health facility. To ensure
adherence until treatment completion, keeping track of patients is paramount. This study aimed to investigate treatment outcomes
of patients who transferred out from the University of Gondar Hospital. Methods. This was a retrospective cohort evaluation
of patients registered from 2009 to 2013. Treatment outcomes were collected from the TB registers of receiving units using a
standardized data capture format. Results. During the study period 3,707 patients initiated treatment and 47.5% (1,760) transferred
out. The study evaluated the outcome of 26% (457/1,760) patients, of whom 403 (88%) arrived in the receiving units. Overall,
79% were successfully treated and 13.8% transferred out for a second time. For all transferred-out cases, treatment outcomes were
not reported to the referring unit. Conclusion and Recommendation. About half of the patients were transferred out to complete
treatment elsewhere. Although successful treatment outcome was obtained in 79% of patients, these results were not fed back to
the referring unit. Implementing a clear mechanism to communicate the arrival of and treatment outcome for transfer-out patients
and appropriate patient education on treatment unit selection before treatment and during transfer-out are recommended.
1. Introduction
In Ethiopia, tuberculosis (TB) remains a major public health
problem [1]. According to the Global TB Report 2015,
Ethiopia is one of the 30 high TB burden countries and one
of the 14 that have a high burden of TB, TH-HIV, and MDR-
TB [2].The directly observed treatment short course (DOTS)
strategy has been implemented in the country since 1994
to control the TB epidemic [3]. Despite 100% geographical
and 92% health facility coverage of the DOTS programme
[3], noncompliance, low case detection, a high transfer-out
rate, and deficient recording and reporting systems are still a
challenge [4].
Globally, all national TB control programmes experience
the challenges of intracountry movement of patients from
one treatment center to another [2]. A transfer-out patient
is a patient who has been transferred out at any time
during treatment to continue treatment at another facility
[5]. The proportion of transferred-out patients varies from
one country to another. Reports indicate that in Sub-Saharan
Africa it can range from 1% to 26% [6, 7]. In Ethiopia figures
from 31% to 66% have previously been reported [8–10].
Treatment outcome is a key indicator in TB control and
serves as a proxy of quality of TB treatment in a health
care system [11]. A study in the UoGH showed that between
2003 and 2008, 42% of TB patients were transferred out
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to continue their treatment at nearby health units [9]. The
Ethiopian Clinical and Programmatic Management of TB,
TB/HIV and Leprosy guidelines [2] indicate that the outcome
for transferred-out patients should be reported to the national
surveillance system by the transferring unit, as this unit
notified and initiated treatment for this patient. Monitoring
treatment outcomes is essential in order to evaluate the
effectiveness of the DOTS program [12]. This would make
it possible to recognize and amend system failures before
the incidence and proportion of resistant isolates rise [11].
However, there are limited studies conducted to assess the
treatment outcome of PTB patients who are transferred out.
Moreover, in view of the large number of transferred out
patients in UoGH, it is important to know what their final
treatment outcomes are and whether they are available at
the transferring facility for them to be captured in the TB
surveillance system. Therefore, this study was conducted to
assess the TB treatment outcomes of transferred-out PTB
patients who were registered and started treatment at UoGH.
2. Methods
2.1. Study Area. UoGH is a tertiary hospital serving the
population of Gondar town and the remote hilly areas of
northwest Ethiopia. The hospital has a DOTS clinic that has
been operational since 2000 [13]. Around 740 TB patients are
diagnosed and treated according to the national guidelines
annually. The primary aim of the study was to evaluate treat-
ment outcomes of PTB patients who had been transferred out
from UoGH and who had arrived at their receiving centers.
For logistic and resource reasons, only centers which were
within a 180 km radius of Gondar town were included; these
were fifteen centers.
2.2. Study Design and Data Collection. A retrospective anal-
ysis of the profile of transferred-out PTB patients registered
at DOTS clinic of UoGH in the years 2009 to 2013 was
conducted. Data were collected from March to June 2014.
The registration documents reviewed contained basic infor-
mation, such as age, sex, and sputum status, type of TB by
history, HIV status, and phase of treatment at the time of
transfer. Patients whose names, father’s names, age, and sex
matched between the registers at the UoGH and the receiving
units and were classified as “transfers-in” in the receiving
units were defined as “arrivals.” Patients whose names did not
appear in the receiving units were defined as “nonarrivals.”
For “arrivals,” treatment outcome was collected from the TB
treatment registers of the receiving centers.
2.3. Definitions. The treatment outcome was categorized
according to National TB and Leprosy Control Program
(NTLCP) guidelines [13]. These categories were being cured
(finished treatment with negative bacteriology result at the
end of treatment), completed treatment (finished treatment,
but without bacteriology result at the end of treatment for
those who are smear-positive), failure (remaining smear-
positive at five months despite correct intake of medication),
default (patientswho interrupted their treatment for two con-
secutive months or more after registration), death (patients
who died from any cause during the course of treatment),
transfer-out (patients whose treatment results are unknown
due to transfer to another health facility), and successful
treatment (a patient who was cured or completed treatment).
2.4. Statistical Analyses and Ethical Considerations. Data
were entered, cleaned, and analyzed using the statistical
package SPSS for Windows, version 20. Inconsistencies in
data entry were randomly checked by reentering 10% of
the raw data. Frequencies and percentages were used to
describe patient characteristics and treatment outcomes. The
study was approved by the Institutional Review Board of the
University of Gondar. In addition, official permission was
secured from the Regional Health Bureau of Amhara region
as well as the involved treatment units.
3. Results
3.1. Characteristics of Transferred-Out Patients. During the
study period 3,707 PTB patients were registered and initiated
the treatment at UoGH DOTS clinic. Among these, 47.5%
(1,760/3,707)were transferred out to complete their treatment
in different treatment units after his/her transfer request.
Of these patients, 25.9% (457/1,760) were transferred to
the fifteen selected units and their outcome was evaluated.
Most of these transferred-out patients (see Table 1) were
smear-negative (76.4%), male (59.3%), and new (91.9%) and
in the age group of 19–34 years (40.0%). All the transferred-
out patients were offered Provider Initiated HIV Testing
and Counseling (PITC) at UoGH and accepted to be tested.
The TB-HIV coinfection rate was 37.9% (173/457) and 44
of those patients (27.1%) were on cotrimoxazole prophylaxis
and 54 (33.3%) on antiretroviral therapy at the time of
transfer. About two-thirds of the patients (309/457, 68%)were
transferred out during the intensive phase. The median time
between treatment initiation and transfer-out was 46 days
(range 9 to 140 days).
In the TB registers of the receiving units, only 88.2%
(403/457) patients were traced and classified as “arrivals.”The
remaining 54 (11.8%) were classified as “nonarrivals.” Of the
“nonarrivals,” 9 (16.6%) were pulmonary smear-positive and
17 (31.5%) were HIV positive (Table 1).
3.2. Treatment Outcomes of Transferred-Out PTB Patients.
TB treatment outcomes were analyzed for the 403 “arriving”
patients only (Table 2). More than three-quarters, 78.8%
(318/403), of patients had a successful treatment outcome
(18.8% cured and 60.0% completed treatment) while 85
(21.1%) had an unsuccessful outcome (1.7% defaulted, 4.9%
died, 0.5% failed, and 13.8% transferred out). For all 457
transferred-out patients, feedback on treatment outcomes
was not reported to UoGH by the receiving units.
4. Discussion
Monitoring treatment outcomes is essential in order to evalu-
ate the effectiveness of theDOTSprogram [12].Many patients
are diagnosed and initiate treatment at large hospitals. To
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Table 1: Characteristics of transferred-out PTB patients at the University of Gondar Hospital and those who arrived and did not arrive at
selected receiving units, respectively, Ethiopia, 2009–2013.
Characteristics Transfer-out (𝑁 = 457)number (%)
Arriving (𝑁 = 403)
number (%)
Nonarriving (𝑁 = 54)
number (%)
Sex
Male 271 (59.3) 244 (90.0) 27 (10.0)
Female 186 (40.7) 159 (85.5) 27 (14.5)
Age (years)
≤18 137 (30.0) 111 (81.1) 26 (18.9)
19–34 183 (40.0) 168 (91.8) 15 (8.2)
35–54 106 (23.2) 98 (92.5) 8 (7.5)
≥55 31 (6.8) 26 (83.9) 5 (16.1)
Sputum status (pulmonary TB type)
Smear-positive 108 (23.6) 99 (91.7) 9 (8.3)
Smear-negative 349 (76.4) 304 (87.1) 45 (12.9)
Type of TB by history
New 420 (91.9) 368 (87.6) 52 (12.4)
Relapse 27 (5.9) 26 (96.3) 1 (3.7)
Return after default 4 (0.9) 4 (100.0) 0 (0.0)
Failure 6 (1.3) 5 (83.3) 1 (16.7)
HIV status
Negative 284 (62.1) 247 (86.9) 37 (13.1)
Positive 173 (37.9) 156 (90.2) 17 (9.8)
Duration in which the patient transferred
out after initiation of treatment
<4 weeks 85 (18.6) 79 (92.9) 6 (7.1)
4–12 weeks 365 (79.9) 317 (86.8) 48 (13.2)
>12 weeks 7 (1.5) 7 (100.0) 0 (0.0)
enhance treatment adherence, these hospitals often transfer
out patients to a clinic closer to the patients’ homes, which has
obvious benefits for patients and their families [14, 15]. Differ-
ent studies have shown that receiving care at only one health
facility improves patient compliance thereby reducing the
risk of default [9, 10]. Moreover, receiving care close to home
is also a key factor for compliance, as when people travel far
for daily/weekly DOT they are more likely to default [10, 16].
The current study showed that nearly half of the patients were
transferred out after being started on treatment.Other similar
studies in the same region reported proportions in the 31.4%–
42.0% range [8, 9].The proportion of transferred-out patients
in the current study was slightly higher than observed at
a previous study in UoGH reporting 42% of patients were
transferred out [9] and another study in the region that
reported 31.4% [8]. The current observed higher proportion
could be due to the establishment and expansion of treatment
units, securing supplies of TB medicines in several health
facilities and improving management in the TB program.
These all lead patients to seek continued TB treatment in
the nearby institutions. The result of current study is lower
compared to a study conducted at one hospital in the same
region (Felege Hiwot Hospital in Bahir Dar) in which 65.6%
of patients were transferred out [10].
No patient should be lost when transferred out between
treatment units. However, in the current study, 12% of
patients were classified as “nonarrivals” as their names could
not be identified in the register of the receiving unit. This
proportion of 12%was higher compared to studies conducted
in Laos and Afghanistan in which 4% and 10% of patients
did not arrive and continue treatment at receiving units
correspondingly [14, 17]. For these “nonarrivals” it could
not be ensured whether they had continued their treatment.
If not they continue to spread TB, especially when they
are pulmonary smear-positive. In addition, such treatment
interruption could favor the development of drug resistant
TB. The possible reasons for these “nonarrivals” might be
self-referral to another preferred facility before reaching the
destined receiving unit or theymay have died or discontinued
treatment. This could be linked to patients not following
instructions from the health care providers or providers not
communicating clearly enough with patients or a combina-
tion of both. This needs further investigation.
A high transfer-out rate often results in a lower treatment
success rate as for those for whom the result is not reported
back the result is listed as not-evaluated.
This could jeopardize achieving the set TB control targets.
The Ethiopian National Strategic Plan (2010–2015) has set a
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Table 2: Treatment outcomes of transferred PTB patients who arrived at their receiving facility in northwest Ethiopia, 2009–2013 (𝑁 = 403).
Characteristics Treatment outcomes 𝑛 (%)
Cured Treatment completed Default Failure Death Transfer-out
Age (years)
≤18 17 (22.4) 72 (29.8) 0 (0) 0 (0) 6 (30.0) 16 (28.6)
19–34 29 (38.2) 96 (39.7) 6 (85.7) 2 (100.0) 8 (40.0) 27 (48.2)
35–54 24 (31.6) 57 (23.6) 1 (14.3) 0 (0) 4 (20.0) 12 (21.4)
≥55 6 (7.9) 17 (7.0) 0 (0) 0 (0) 2 (10.0) 1 (1.8)
Sex
Male (=244) 43 (17.6) 145 (59.4) 4 (1.6) 1 (0.4) 14 (5.7) 37 (15.2)
Female (=159) 33 (20.7) 97 (61.0) 3 (1.9) 1 (0.6) 6 (3.8) 19 (11.9)
Sputum status (pulmonary type of TB)
Smear-positive 42 (42.4) 35 (35.3) 2 (2.0) 0 (0) 4 (4.0) 16 (16.2)
Smear-negative 34 (11.2) 207 (60.1) 5 (1.6) 2 (0.6) 16 (5.3) 40 (13.1)
Categories of TB at start
New 66 (17.9) 223 (60.6) 6 (1.6) 2 (0.5) 19 (5.2) 52 (14.1)
Relapse 8 (30.8) 14 (53.8) 0 (0) 0 (0) 1 (3.8) 3 (11.5)
Default 1 (25.0) 2 (50.0) 0 (0) 0 (0) 0 (0) 1 (25.0)
Failure 1 (20.0) 3 (60.0) 1 (20.0) 0 (0) 0 (0) 0 (0)
HIV status
Positive (=155) 23 (14.8) 96 (61.9) 1 (0.6) 1 (0.6) 11 (7.1) 23 (14.8)
Negative (=248) 53 (21.4) 146 (58.8) 6 (2.4) 1 (0.4) 9 (3.6) 33 (13.3)
Time period between transfer-out and
transfer-in (363)
Same to 2nd day 31 (19.3) 91 (56.8) 3 (1.8) 1 (0.6) 13 (8.1) 21 (13.1)
3rd day 35 (19.2) 110 (60.4) 4 (2.2) 1 (0.5) 5 (2.7) 27 (14.8)
≥4th day 5 (23.8) 14 (66.6) 0 (0) 0 (0) 1 (4.8) 1 (4.8)
Phase of TB treatment at time of
transfer-out
Intensive 59 (21.1) 163 (58.2) 5 (1.9) 1 (0.3) 14 (5.0) 38 (13.5)
Continuation 17 (13.8) 79 (64.2) 2 (1.6) 1 (0.8) 6 (4.8) 18 (14.6)
Overall 76 (18.9%) 242 (60.0%) 7 (1.7%) 2 (0.5%) 20 (4.9%) 56 (13.8%)
treatment success target of 90% [1], equal to the global set
target by the WHO [18]. In this study, the overall treatment
success rate for PTB patients who were transferred out was
79% which is lower than both the national and the global
target. Currently, Ethiopia reports a treatment success rate
of 91% for new cases registered in 2012, while for previously
treated cases this is 43% [1].The study result of 79% treatment
success is below this and also lower than previously reported
treatment success rates in northwest Ethiopia ranging from
86% to 95% [19–21] and than Amhara region which reported
a treatment success rate of 87.5% in 2014 [22].
If TB control activities function, all patients who transfer
out to other units should be recorded as transfers-in and
the treatment outcome results communicated back to the
referring units via feedback reports and by telephone [15,
23]. In the current study, none of the transferred-in TB
patients had an outcome communicated to their referral
institution. This suggests that TB reporting systems might
not function optimally with regard to communication on
treatment outcome of transferred patients. Reasons for this
were unclear but it could be due to unawareness of the
need for the procedure, negligence, expecting the other to
report, and/or lack of communication modalities [24]. Lack
of clear guidance and communication between referring and
accepting DOTS clinics requires evaluation and immediate
attention. The primary DOTS clinic should have collected
treatment outcome data from the accepting clinics. Efficient
counseling and follow-up of transferred-out patients are
mandatory to avoid poor treatment outcomes. Developing
clear guidance on how to trace and report transferred-out
cases is essential to avoid spillover of TB and MDR-TB
[24]. Telecommunication facilities are an area in need of
improvement as many of the DOT clinics lack this. Also, the
reporting of transferred patients may cause double counting
of patients during routine quarterly reporting to central units
if both the referring and receiving facility are notifying the
patient. This should be looked into.
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5. Limitations of the Study
The current study had several limitations: Firstly, it is specific
to one setting which may make it difficult to extrapolate the
findings to other settings. Secondly, due to the inherent fea-
tures of a retrospective study design missing data/incomplete
records may have influenced the results. Thirdly, the study
unfortunately did not include a control group of patients
that were not transferred out for comparison purposes.
Fourthly, the linking between facility records was done using
name matching and not with a unique identifier. Also, TB
treatment outcomes were not available for the “nonarrivals”
and their exclusion might have biased the treatment success
rate. Despite the above limitations, the study result provided
important insights into TB control for policy makers and
TB program managers and identified the need to strengthen
communication for transferred-out cases to ensure the
surveillance data accurately reflect the number of patients on
treatment as well as treatment outcomes of all TB cases.
6. Conclusion and Recommendation
In conclusion, at UoGH about half of TB patients were trans-
ferred out to complete treatment elsewherewhile 14%of them
were transferred out for a second time. Successful treatment
outcome was obtained in 79% of transferred-out patients.
However these results are not fed back to the referring
facilities that should formally report the outcomes for these
cases. This results in underreporting of successful treatment
outcomes. A clear mechanism should be implemented to
communicate the arrival of and treatment outcomes for
transfer-out patients to ensure all patient information is up to
date for adequate monitoring of TB control activities. Appro-
priate patient education on treatment unit selection before
treatment and during transfer-out is also recommended.
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